Bioptamers
New Castle · Founded 2018
About Bioptamers
We are developing a platform to optimise the aptamer selection to personalise cancer therapy matching the specific patient needs. Our development process will convert those molecules into valuable clinical products to license for pharmaceutical companies.
Company Facts
- Founded: 2018
- Legal name: Bioptamers Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Mar 2019)
- Website: bioptamers.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/bioptamers-8293311 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.